Skip to main navigation
Cartesian Therapeutics, Inc
  • About Us
    • Leadership
    • Board of Directors
    • Advisors
  • Science
    • mRNA Cell Therapy
    • Proprietary Platform
    • Manufacturing
    • Publications & Presentations
  • Pipeline
    • Descartes-08
    • Descartes-15
  • Patients
    • Clinical Trials
    • Patient Resources
  • Careers
  • Investors
    • Overview
    • News & Events
    • Stock Information
    • Financial Information
    • Corporate Governance
    • Investor Resources

SEC Filing Details

Financial Information
  • SEC Filings
  • Annual Reports

Document Details

Form
10-K
Filing Date
March 15, 2019
Document Date
December 31, 2018
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Cartesian Therapeutics, Inc
Issuer
CARTESIAN THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT
  • About Us
  • Science
  • Pipeline
  • Patients
  • Careers
  • Investors
  • Go to linkedin page
  • Go to Twitter page

7495 New Horizon Way, Frederick, MD 21703

info@cartesiantx.com

  • Global Privacy Notice
  • HCP Privacy Notice
  • Vendor Privacy Notice
  • Terms of Service
  • FCOI Policy
  • Expanded Access Policy
Cartesian Therapeutics, Inc

©2026 Cartesian Therapeutics, Inc. All Rights Reserved.